Table 2.
Demographic Characteristics (Per-Protocol Immunogenicity Analysis Set, Both Age Cohorts)
| Parameter, n (%) | NVX-CoV2373 N = 717 |
Placebo N = 346 |
Total N = 1063 |
|---|---|---|---|
| Sex | |||
| Male | 366 (51.0) | 165 (47.7) | 531 (50.0) |
| Female | 351 (49.0) | 181 (52.3) | 532 (50.0) |
| Age (years) | |||
| Mean (SD) | 57.1 (15.73) | 56.6 (16.74) | 57.0 (16.06) |
| Median | 64.0 | 65.0 | 65.0 |
| Min–max | 18–95 | 18–87 | 18–95 |
| Age group | |||
| 18–64 years | 359 (50.1) | 171 (49.4) | 530 (49.9) |
| ≥65 years | 358 (49.9) | 175 (50.6) | 533 (50.1) |
| Race | |||
| White | 573 (79.9) | 265 (76.6) | 838 (78.8) |
| Black or African American | 62 (8.6) | 47 (13.6) | 109 (10.3) |
| American Indian or Alaska Native | 49 (6.8) | 16 (4.6) | 65 (6.1) |
| Native Hawaiian or Other Pacific Islander | 0 | 1 (0.3) | 1 (<0.1) |
| Asian | 20 (2.8) | 14 (4.0) | 34 (3.2) |
| Mixed origin | 10 (1.4) | 2 (0.6) | 12 (1.1) |
| Not reported | 3 (0.4) | 1 (0.3) | 4 (0.4) |
| Ethnicity | |||
| Hispanic or Latino | 143 (19.9) | 61 (17.6) | 204 (19.2) |
| Not Hispanic or Latino | 573 (79.9) | 285 (82.4) | 858 (80.7) |
| Not reported | 1 (0.1) | 0 | 1 (<0.1) |
| Country | |||
| Mexico | 50 (7.0) | 23 (6.6) | 73 (6.9) |
| United States | 667 (93.0) | 323 (93.4) | 990 (93.1) |
Abbreviations: SD, standard deviation.